Fewer trips to the hospital? new cervical cancer radiation trial aims to cut treatment time
NCT ID NCT07605507
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a shorter, higher-dose radiation schedule (hypofractionated) to the standard longer schedule for cervical cancer patients also receiving chemotherapy. The goal is to see if the shorter schedule is just as safe and effective, while reducing the number of hospital visits. Forty participants will be randomly assigned to one of the two radiation approaches, and researchers will track side effects, tumor response, and quality of life over five years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Radiation therapy (hypofractionated or conventional) with cisplatin chemotherapy
- What this could lead to
- If successful, this could offer a more convenient treatment option for cervical cancer patients, requiring fewer hospital visits while maintaining safety and effectiveness.
- What could go wrong
- This is a small, early-phase trial with only 40 participants, so results may not apply to all patients. The higher radiation dose per session could increase side effects, and the study is not designed to prove long-term survival benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Siriraj Hospital
Bangkok, Bangkok, Thailand
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can an antiviral make radiation more effective against cervical cancer?
- A One-Two punch against cervical cancer: testing plus vaccination in HIV-Positive women
- Can a Two-Antibody combo outsmart advanced cancer?
- Can robotic surgery match open surgery in beating cervical cancer?
- Blood test clues could sharpen cervical cancer treatment